Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in REM Sleep Behavior Disorder
Objective: To determine if there is evidence of cholinergic basal forebrain degeneration, i.e., reduced cholinergic nucleus 4 (Ch4) volume on MRI, in patients with REM…White Matter Perivascular Spaces in Parkinson’s Disease are Associated with Decreased Cognition, Interrupted Sleep, and Less Physical Activity
Objective: To determine the association of Perivascular Spaces (PVS) and non-motor features in Parkinson’s disease (PD). Background: PVS are the fluid-filled spaces surrounding blood vessels…Pronunciation characteristics of patients with Parkinson’s disease based on sustained vowel speech
Objective: This study attempted to objectively analyze the acoustic characteristics of PD by using dynamic laryngoscope DIVAS2.5 acoustic analysis system and Praat acoustic software, and provide…PLA2G6-related dystonia-parkinsonism in identical twins manifesting at an advanced age: a case report and review of the literature.
Objective: To report a rare presentation of a rare disease and illustrate the range of phenotype seen in PLA2G6-associated dystonia-parkinsonism (PLADP). Background: PLA2G6 encodes a…Sex differences in vascular risk factors for Parkinson’s disease
Objective: Our aim is to illustrate the incidence of vascular risk factors (VRF) in a cohort of patients with confirmed Parkinson's disease (PD) and characterize…Priorities of PD patients for treatment of cognitive-driven ADL impairment
Objective: To define cognitive-driven impairments in activities of daily living (ADL) with high priority for rehabilitation ranked by Parkinson’s disease (PD) patients. Background: Impairments in…Gait under unsupervised, but not supervised conditions, differentiates between Parkinson disease with and without fatigue
Objective: To Assess the impact of fatigue on gait in Parkinson Disease patients in different evaluation conditions. Background: Fatigue is a common and disabling symptom…Improving timely administration of PD meds in the hospital by using “custom” schedules
Objective: To determine if there are differences in timely administration of medications in hospitalized patients with Parkinson’s Disease (PD) when orders are placed for a…Cognitive profiles at presentation and subsequent cognitive decline in PD-MCI.
Objective: To determine cognitive profiles in a Parkinson‘s Disease-Mild Cognitive Impairment (PD-MCI) cohort, and study the relationship between baseline cognitive phenotype and subsequent cognitive decline.…Nigral microvasculature imaging in Parkinson’s disease
Objective: The goal of this work is to image the microvasculature of the midbrain, in particular the substantia nigra in Parkinson’s disease (PD) patients using…
- « Previous Page
- 1
- …
- 227
- 228
- 229
- 230
- 231
- …
- 338
- Next Page »